Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Trial ID or NCT#
NCT00656019
Status
NOT RECRUITING
Purpose
This study will assess whether levels of vitamin D impact the characteristics of a woman's breast cancer at diagnosis, and whether a short course of vitamin D in women with low levels of vitamin D changes the gene expression of their breast cancers.
Official Title
Development of Vitamin D as a Therapy for Breast Cancer - Phase 2
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Investigator(s)
Kristin Jensen
Pathologist,
Cytopathologist,
Immunodiagnosis pathologist,
Surgical pathologist
Associate Professor of Pathology at the Palo Alto Veteran's Health Care System and at Stanford University Medical Center
David Feldman
Contact us to find out if this trial is right for you.
Contact
Charlene Kranz
6504987977
View on ClinicalTrials.gov
